Akili Interactive Labs
-
Q4 Was Digital Health’s Worst Quarter for Funding in 5 Years
Digital health’s investment slowdown is so severe that the fourth quarter of 2022 marked the lowest quarterly digital health funding total in the past five years, according to new report. Q4 was also the first quarter with no new unicorn births since 2018.
-
New study shows first FDA-cleared video game treatment for pediatric ADHD improves brain function
In the U.S., EndeavorRx has been cleared to help in improving attention function as measured by computer-based testing in children ages 8-12 years who have primarily inattentive or combined-type ADHD who struggle with maintaining attention.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Health IT, Hospitals, Startups
Gaming guru: Gamification of health is marketers selling snake oil, but gaming has powerful applications
A top gaming expert believes that gaming technologies have important applications in healthcare but the term “gamification of health” should be jettisoned.
-
Rock Health: Digital health investing has already surpassed record-breaking 2017
In 2018 alone, ten companies have inked mega-deals of more than $100 million including Livongo, 23andMe and American Well.
-
Akili raises $55M as it prepares to submit prescription video game for people with ADHD for FDA approval
Temasek led the Series C and another new investor took part in the round — Baillie Gifford. Other investors in the round included Amgen Ventures, M Ventures (the CVC fund of Merck KGaA, Darmstadt, Germany), JAZZ Venture Partners, Canepa Advanced Healthcare Fund, and Brooklands Capital Strategies.
-
Akili adds former pharma CEO, gaming execs to management team
Former Cubist Pharmaceuticals veteran Rob Perez will serve as executive chairman at Akili Interactive Labs, which has a pediatric ADHD digital therapeutic in Phase 3 development.
-
Study: Using a video game to spot early signs of Alzheimer’s gets positive clinical validation
A double blind study by Akili Interactive Labs and Pfizer offered some positive findings for using a video game platform as a screening tool to spot early signs of cognitive decline before symptoms show.
-
ADHD game developer Akili Labs raises another $11.9M
The money will also boost Akili’s expansion into treatments for major depressive disorder and cognitive decline associated with multiple sclerosis and Parkinson’s disease.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Akili Interactive Labs raises $30.5M to advance clinical trials as it readies for FDA application
Among the investors taking part in the round are JAZZ Venture Partners, Canepa Advanced Healthcare Fund and PureTech Health.
-
In gamification milestone, Pfizer will assess video game in clinical trial for Alzheimer’s disease
In a move that could have a significant impact on how pharmaceutical companies view gamification, […]